-
Nov 25, 2024 | 
kff.org | Meredith Freed |Tricia Neuman |Juliette Cubanski
NOTE: This analysis was updated in November 2024 to reflect changes in the most recent Physician Fee Schedule Final Rule. Medicare does not offer broad coverage of dental services under traditional Medicare, but through recent regulatory action, the Biden Administration has taken steps to modify Medicare payment policies to expand the types of dental services that are covered.
-
Oct 11, 2024 | 
kff.org | Tricia Neuman |Alice Burns |Robin Rudowitz
On October 8, 2024, Vice President Harris proposed to expand Medicare to provide home care to help families who are struggling with the costs of long-term care. If enacted, this would be the first major expansion of Medicare since the Medicare Modernization Act of 2003 that added a prescription drug benefit to the program. Vice President Harris proposes to create a new home care benefit for eligible Medicare beneficiaries.
-
Sep 24, 2024 | 
theoncologypharmacist.com | William King |Juliette Cubanski |Tricia Neuman |Charlie Dawson
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Aug 19, 2024 | 
kff.org | Tricia Neuman |Juliette Cubanski |Larry Levitt
Authored by KFF’s Tricia Neuman, Juliette Cubanski and Larry Levitt, this post for Health Affairs Forefront examines how the results of the first-ever Medicare drug price negotiations will generate savings for the government and for Medicare beneficiaries, and how candidates’ views on the issue could play a role in the upcoming elections and in shaping the future of government negotiation of drug prices.
-
Aug 19, 2024 | 
healthaffairs.org | Tricia Neuman |Juliette Cubanski |Larry Levitt
On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced negotiated prices for the first 10 drugs selected under Medicare’s new Drug Price Negotiation Program, established by the Inflation Reduction Act of 2022. This announcement marked the end of a months-long negotiation process between CMS and the manufacturers of these 10 drugs, with new prices taking effect for Medicare beneficiaries on January 1, 2026.
-
Aug 1, 2024 | 
kff.org | Juliette Cubanski |Tricia Neuman
The Inflation Reduction Act of 2022 includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government, including several changes to the Part D benefit.
-
May 30, 2024 | 
kff.org | Juliette Cubanski |Tricia Neuman
Funding for Medicare, which totaled $1 trillion in 2023, comes primarily from general revenues (government contributions), payroll tax revenues paid by employers and workers, and premiums paid by beneficiaries.
-
Apr 12, 2024 | 
kff.org | Tricia Neuman |Anthony Damico
Employer- and union-sponsored retiree health benefits have served as an important source of supplemental coverage for people on Medicare. Retiree health plans have helped fill the gaps in Medicare’s benefit design by filling in some or all of Medicare’s deductibles and cost-sharing requirements and offering benefits that are not covered by traditional Medicare, such as dental and vision and a cap on out-of-pocket spending.
-
Mar 11, 2024 | 
kff.org | Meredith Freed |Tricia Neuman |Juliette Cubanski
The high cost of prescription drugs continues to be a top health care priority for the public. Policymakers from both parties at the federal and state level have been pursuing a range of options to lower drug prices for Americans, one of which would allow for the safe importation of prescription drugs from Canada. This idea is based on data showing that people in the U.S. often pay more for medications than people in other countries.
-
Jan 12, 2024 | 
kff.org | Meredith Freed |Juliette Cubanski |Tricia Neuman
On January 5, 2024, the FDA authorized the state of Florida to import certain prescription drugs from Canada, an approach designed to give Floridians access to lower drug prices paid by people in Canada. This announcement has received a great deal of attention because it is the first time the FDA has granted authority for a state to safely import prescription drugs from another country.
